Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents View on Open Library

Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents

by Canadian Coordinating Office for Health Technology Assessment

No reviews yet
First published: 2002 1 language ISBN: 1894620577
Subjects
Chemotherapy Hypoglycemic agents Diabetes Cost-Benefit Analysis Cost effectiveness Drug therapy Diabetes Mellitus Therapeutic use Hypoglycemic Agents

Reviews

Log in or sign up to write a review.

No reviews yet. Be the first!

More by Canadian Coordinating Office for Health Technology Assessment

Guidelines for economic evaluation of pharmaceuticals: Canada

Guidelines for economic evaluation of ph...

Guidelines for economic evaluation of pharmaceuticals, Canada

Guidelines for economic evaluation of ph...

An international inventory of health care technology assessment reports and projects

An international inventory of health car...

You Might Also Like

More in Chemotherapy
The mis-education of the Negro

The mis-education of the Negro

Carter Godwin Woodson
Advances in Virus Research

Advances in Virus Research

Thomas Mettenleiter
Advances in Chromatography

Advances in Chromatography

J. Calvin Giddings
Clinical drug therapy

Clinical drug therapy

Anne Collins Abrams
Clinical pharmacology

Clinical pharmacology

Laurence, D. R.
Symptoms in the pharmacy

Symptoms in the pharmacy

Alison Blenkinsopp